title: Extracorporeal development and ultrarapid freezing of human fetal ova.
abstract: OBJECTIVE
  The present study was performed to culture human fetal ova to determine whether they can be matured and cryopreserved using ultrarapid freezing.
  
  
  METHODS
  Thirty-three pairs of fetal ovaries were obtained from fetuses of 16-20 weeks' gestation following elective abortion. Ovarian tissues were minced into approximately 1-mm sizes and cultured in Waymouth media either before or after ultrarapid freezing. The Waymouth medium was supplemented with 15% (v/v) fetal bovine serum, 0.03 IU/ml FSH and 35 ng/ml insulin. The tissue was cultured at 37 degrees C in 5% CO2 in air for 5-25 days in Falcon dishes and 30-40 days in Costar Transwell-COL membranes prior to induction of final maturation in the presence of LH and human follicular fluid. Minced tissues were also frozen by ultrarapid freezing in M199 with 4.2 M dimethylsulfoxide (DMSO) and 0.35 M sucrose and plunged directly into liquid nitrogen. For thawing, the straws were plunged into a 37 degrees C water bath for 5 s. The contents were then expelled and diluted 1:5 with thawing medium containing 0.42 M sucrose. After washing the thawed tissues were cultured as described for the fresh tissues.
  
  
  RESULTS
  Patches of monolayer consisting of fibroblasts had formed within 2-3 days of culture of fresh tissues. After 1 week of culture, follicles separated out from the ovarian tissue but remained attached to the monolayer. The maximal number of follicles separating out from the tissue appeared about 1 week after initiating the culture (154 follicles per 10 fields at Day 5 and 61 and Day 25). After 40 days of culture in Costar dishes, 34% of the ova reached a diameter of more than 80 microns, which was significantly higher than at the beginning of culture (6%; P < 0.05). Among these ova, 34% were found to be surrounded by the zona pellucida, which was not observed at the beginning of culture. Following induction of final maturation, extrusion of the first polar body was noted in 25% of ova grown in Costar dishes for 40 days. Twelve percent of the oocytes showed the first polar body when they were grown in Costar dishes for less than 30 days. For frozen-thawed tissues, 14% of minced ovarian tissues displayed central necrosis immediately after thawing. Following digestion and Trypan blue staining, 75% of ova and 85% of somatic cells survived ultrapid freezing. Nineteen percent of the ova which have been cultured as described for fresh tissues displayed extrusion of the first polar body, comparing favorably with the 25% maturation rate observed with the fresh tissue (P > 0.05).
  
  
  CONCLUSIONS
  This study demonstrates that morphologically normal, mature human ova can be obtained from primordial follicles in vitro development. Using a simple, quick ultrarapid freezing method, human fetal ova can be cryopreserved in the form of minced tissue without significantly compromising their ability to grow in vitro.
authors.affiliation: Dominion Fertility and Endocrinology, Arlington, Virginia, USA.
authors.forename: J
authors.initials: J
authors.lastname: Zhang
authors.forename: J
authors.initials: J
authors.lastname: Liu
authors.forename: K P
authors.initials: KP
authors.lastname: Xu
authors.forename: B
authors.initials: B
authors.lastname: Liu
authors.forename: M
authors.initials: M
authors.lastname: DiMattina
mesh_terms: D000818:Animals; D002417:Cattle; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D015925:Cryopreservation / Q000379:methods*; D003451:Cryoprotective Agents / Q000032:analysis / Q000494:pharmacology; D003470:Culture Media / Q000032:analysis / Q000494:pharmacology; D004121:Dimethyl Sulfoxide / Q000032:analysis / Q000494:pharmacology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000032:analysis / Q000494:pharmacology; D015571:Follicular Fluid / Q000502:physiology; D006801:Humans; D007328:Insulin / Q000032:analysis / Q000494:pharmacology; D007986:Luteinizing Hormone / Q000494:pharmacology; D009865:Oocytes / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D009866:Oogenesis / Q000502:physiology; D010053:Ovary / Q000166:cytology* / Q000196:embryology*; D010063:Ovum / Q000166:cytology / Q000187:drug effects / Q000254:growth & development*; D012710:Serum Albumin, Bovine / Q000032:analysis / Q000494:pharmacology; D015044:Zona Pellucida / Q000502:physiology
chemical_list: D003451:Cryoprotective Agents; D003470:Culture Media; D007328:Insulin; D012710:Serum Albumin, Bovine; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D004121:Dimethyl Sulfoxide